Oncothyreon ONT 380-206
Research Grant
Administered By
Duke Cancer Institute
Awarded By
Cascadian Therapeutics Inc.
Start Date
October 11, 2016
End Date
December 31, 2023
Administered By
Duke Cancer Institute
Awarded By
Cascadian Therapeutics Inc.
Start Date
October 11, 2016
End Date
December 31, 2023